Striatal Shape Alteration as a Staging Biomarker for Parkinson's Disease - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Neuroimage-Clinical Année : 2020

Striatal Shape Alteration as a Staging Biomarker for Parkinson's Disease

Résumé

Parkinson's Disease provokes alterations of subcortical deep gray matter, leading to subtle changes in the shape of several subcortical structures even before the manifestation of motor and non-motor clinical symptoms. We used an automated registration and segmentation pipeline to measure this structural alteration in one early and one advanced Parkinson's Disease (PD) cohorts, one prodromal stage cohort and one healthy control cohort. These structural alterations are then passed to a machine learning pipeline to classify these populations. Our workflow is able to distinguish different stages of PD based solely on shape analysis of the bilateral caudate nucleus and putamen, with balanced accuracies in the range of 59% to 85%. Furthermore, we compared the significance of each of these subcortical structure, compared the performances of different classifiers on this task, thus quantifying the informativeness of striatal shape alteration as a staging bio-marker for PD.
Fichier principal
Vignette du fichier
PANDA_preprint.pdf (295.29 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02571267 , version 1 (12-05-2020)
hal-02571267 , version 2 (18-05-2020)

Identifiants

Citer

Maxime Peralta, John Baxter, Ali R Khan, Claire Haegelen, Pierre Jannin. Striatal Shape Alteration as a Staging Biomarker for Parkinson's Disease. Neuroimage-Clinical, 2020, 27, ⟨10.1016/j.nicl.2020.102272⟩. ⟨hal-02571267v2⟩
59 Consultations
133 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More